- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.11. | Aktie von agilon health fällt nach NYSE-Mitteilung über Nichterfüllung der Börsenzulassungsregeln | 1 | Investing.com Deutsch | ||
| 07.11. | agilon health plant Reverse-Split zur Erfüllung der NYSE-Börsenanforderungen | 2 | Investing.com Deutsch | ||
| AGILON HEALTH Aktie jetzt für 0€ handeln | |||||
| 07.11. | agilon health, inc. - 8-K, Current Report | - | SEC Filings | ||
| 05.11. | Agilon health reinstates $5.82B revenue guidance for 2025 while streamlining cost base | 2 | Seeking Alpha | ||
| 05.11. | Agilon Health Q3 2025 slides: wider losses amid strategic repositioning for 2026 | 3 | Investing.com | ||
| 04.11. | agilon health, inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 29.09. | Agilon Health: Benchmark bestätigt Kaufempfehlung angesichts der Aussichten für 2026 | 13 | Investing.com Deutsch | ||
| 29.09. | Benchmark maintains Buy rating on agilon health stock amid 2026 outlook | 1 | Investing.com | ||
| 20.08. | Bernstein stuft agilon health wegen Margendrucks herab | 9 | Investing.com Deutsch | ||
| 20.08. | Bernstein downgrades agilon health stock on margin pressures | 1 | Investing.com | ||
| 06.08. | Agilon Health Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) | 2 | Benzinga.com | ||
| 05.08. | Barclays halbiert Kursziel für agilon health nach EBITDA-Verfehlung | 10 | Investing.com Deutsch | ||
| 05.08. | agilon health Q2 2025 slides: CEO exits amid significant financial headwinds | 2 | Investing.com | ||
| 04.08. | agilon health GAAP EPS of -$0.25 misses by $0.13, revenue of $1.4B misses by $70M | 23 | Seeking Alpha | ||
| 04.08. | agilon health stock plunges after CEO steps down amid earnings miss | 1 | Investing.com | ||
| 04.08. | CEO-Rücktritt und schwache Zahlen: Aktie von agilon health bricht ein | 6 | Investing.com Deutsch | ||
| 04.08. | agilon health CEO steps down; interim lead appointed | 1 | Seeking Alpha | ||
| 04.08. | agilon health, inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 04.08. | agilon health, inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.07. | Where Agilon Health Stands With Analysts | 1 | Benzinga.com |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 19,150 | -1,95 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BILLIONTOONE | 86,34 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,880 | +0,49 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| BRIGHTSPRING HEALTH SERVICES | 37,730 | -0,13 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 25,510 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 136,12 | +0,57 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,690 | -0,17 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| LIFEMD | 4,000 | +15,61 % | Morning Market Movers: Olema Pharmaceuticals, LifeMD, Alpha Technology Group, Intellinetics See Big Swings | HELSINKI (dpa-AFX) - At 8:10 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ADAPTHEALTH | 10,240 | +1,29 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| BETA BIONICS | 31,090 | -0,83 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTFLOW | 30,500 | 0,00 % | Hedge Fund and Insider Trading News: Ken Griffin, Warren Buffett, Israel Englander, Viking Global, Point72 Asset Management, Heartflow Inc (HTFL), Teva Pharmaceutical Industries Ltd (TEVA), and More | ||
| CERIBELL | 21,420 | +0,61 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| RXSIGHT | 11,460 | +4,09 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| CLEARPOINT NEURO | 14,490 | +0,84 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| HEARTBEAM | 2,585 | -5,66 % | Heartbeam stock is a buy, this analyst says |
Das Unternehmen AGILON HEALTH INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,702 Euro und damit +1,99 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AGILON HEALTH INC finden Sie auf Wallstreet Online.